Document Detail

A preventive approach of the postmenopausal bone loss.
MedLine Citation:
PMID:  2701148     Owner:  NLM     Status:  MEDLINE    
In countries where osteoporosis in the ageing process tends to be a major problem, this phenomenon is of particular interest. The consequences of the osteoporosis in an ageing population, especially in the coming decades could create serious problems for the health authorities. It would be very interesting to see that in an early stage i.e. at menopause it could be influenced by prophylactic treatments. In a few countries the prophylactic approach of the menopausal osteoporosis has been already introduced. But it will take a long time before prophylaxis of postmenopausal osteoporosis could be considered as a standard and routine procedure.
L J Jaszmann
Related Documents :
17227738 - Bone mineral density and its related factors in elderly male chinese patients with type...
11199188 - Osteocalcin gene polymorphism is related to bone density in healthy adolescent females.
12102258 - The prevalence of osteopenia in pediatric renal allograft recipients varies with the me...
18839048 - Age-related changes in sex steroid levels influence bone mineral density in healthy ind...
23571338 - Effect of age on hepatic cytochrome p450 of ross 708 broiler chickens.
2521108 - The hazards of cognitive aging.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Acta physiologica Hungarica     Volume:  74     ISSN:  0231-424X     ISO Abbreviation:  Acta Physiol Hung     Publication Date:  1989  
Date Detail:
Created Date:  1990-08-27     Completed Date:  1990-08-27     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8309201     Medline TA:  Acta Physiol Hung     Country:  HUNGARY    
Other Details:
Languages:  eng     Pagination:  321-8     Citation Subset:  IM    
Regional Protestant Hospital, Out-patient's Clinic for Climacterics, Bennekom, Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Estrogens / therapeutic use
Netherlands / epidemiology
Osteoporosis, Postmenopausal / epidemiology,  prevention & control*
Progesterone / therapeutic use
Reg. No./Substance:
0/Estrogens; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prenatal diagnosis and management of chondrodysplasias.
Next Document:  Endocrine factors in the neonatal adaptation.